Glucose stimulates pulsatile insulin secretion from human pancreatic islets by increasing secretory burst mass: dose-response relationships.

Insulin is secreted almost exclusively in discrete bursts, and physiological regulation is accomplished by modulation of the pulse mass. How the integrity of contiguous anatomic structures in the human pancreas (islets, splanchnic innervation, exocrine tissue, local hormones) directs the coordinated insulin secretion is not known. We posed the hypothesis that glucose stimulates insulin secretion from isolated human islets by an amplification of insulin pulse mass with no change in pulse frequency and that the glucose dose-response curve for the regulation of insulin pulse mass mirrors that recognized in vivo. Islets from five nondiabetic cadaveric donors were perifused in a recently validated perifusion system at 4 mM and subsequently at 8, 12, 16, or 24 mM glucose. The effluent was collected in 1-min intervals and used for the measurement of insulin (ELISA). Pulsatile insulin secretion was analyzed by deconvolution analysis. Total insulin secretion increased progressively (P < 0.0001). This augmentation was due to amplified pulse mass (3-fold, 24 mM vs. 4 mM glucose; P < 0.0001) with no change in pulse interval (approximately 4 min). Pulsatile insulin secretion was stimulated most effectively in a physiologic concentration range of 4-8 mM. The islet insulin content was significantly correlated to the magnitude of first and second phase insulin secretion (P < 0.0001). The quantifiable orderliness of pulsatile insulin secretion rose with escalating glucose concentration (P = 0.02). In conclusion, glucose stimulates pulsatile insulin secretion from isolated human islets by amplification of insulin pulse mass without altering pulse interval. The in vitro concentration-response relationship is comparable with that observed in vivo. These data imply that transplanted human islets should be able to reproduce glucose-regulated insulin secretion as observed in the intact human pancreas.

[1]  N. Porksen,et al.  Impact of sampling technique on appraisal of pulsatile insulin secretion by deconvolution and cluster analysis. , 1995, The American journal of physiology.

[2]  R. Eaton,et al.  Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. , 1986, The Journal of clinical endocrinology and metabolism.

[3]  P. Butler,et al.  Pulsatile insulin secretion by human pancreatic islets. , 2002, The Journal of clinical endocrinology and metabolism.

[4]  S M Pincus,et al.  Approximate entropy as a measure of system complexity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M L Johnson,et al.  The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. Porksen,et al.  Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. , 2000, American journal of physiology. Endocrinology and metabolism.

[7]  Ferdinand Roelfsema,et al.  Hormone pulsatility discrimination via coarse and short time sampling. , 1999, American journal of physiology. Endocrinology and metabolism.

[8]  J D Veldhuis,et al.  Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[10]  P. Bergsten,et al.  Glucose metabolism and pulsatile insulin release from isolated islets. , 2001, Diabetes.

[11]  J. Deeney,et al.  Glucose-induced oscillatory insulin secretion in perifused rat pancreatic islets and clonal beta-cells (HIT). , 1996, The American journal of physiology.

[12]  D. Kipnis,et al.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. , 1967, The Journal of clinical investigation.

[13]  N. Porksen,et al.  Coordinate pulsatile insulin secretion by chronic intraportally transplanted islets in the isolated perfused rat liver. , 1994, The Journal of clinical investigation.

[14]  W. Fujimoto,et al.  Oscillatory insulin secretion in perifused isolated rat islets. , 1989, The American journal of physiology.

[15]  E. Samols,et al.  Perturbation of insulin oscillations by nerve blockade in the in vitro canine pancreas. , 1985, The American journal of physiology.

[16]  Steven M. Pincus,et al.  Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  Y. Hirata,et al.  C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level. , 1986, Acta endocrinologica.

[18]  R. Hoffmann,et al.  Low- and high-frequency insulin secretion pulses in normal subjects and pancreas transplant recipients: role of extrinsic innervation. , 1992, The Journal of clinical investigation.

[19]  G. Boden,et al.  Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. , 1996, The American journal of physiology.

[20]  D. Porte.  β-cells in type II diabetes mellitus , 1991, Diabetes.

[21]  N. Porksen,et al.  Human insulin release processes measured by intraportal sampling. , 2002, American journal of physiology. Endocrinology and metabolism.

[22]  Steven M. Pincus,et al.  Orderliness of hormone release patterns: a complementary measure to conventional pulsatile and circadian analyses. , 1998, European journal of endocrinology.

[23]  P. Lacy,et al.  Pulsatile Insulin Secretion from Isolated Human Pancreatic Islets , 1994, Diabetes.

[24]  J. Holst,et al.  Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. , 2001, Diabetes.

[25]  Steven M. Pincus,et al.  Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  N. Porksen,et al.  Effects of Glucose Ingestion Versus Infusion on Pulsatile Insulin Secretion: The Incretin Effect Is Achieved by Amplification of Insulin Secretory Burst Mass , 1996, Diabetes.

[27]  J D Veldhuis,et al.  Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. , 1997, The American journal of physiology.

[28]  K. Tornheim.  Are Metabolic Oscillations Responsible for Normal Oscillatory Insulin Secretion? , 1997, Diabetes.

[29]  E. Ipp,et al.  Pulsatile Insulin Secretion in Isolated Rat Islets , 1990, Diabetes.

[30]  N. Porksen,et al.  In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. , 1997, American journal of physiology. Endocrinology and metabolism.

[31]  M. Røder,et al.  Enzyme immunoassay for intact human insulin in serum or plasma. , 1993, Clinical chemistry.

[32]  R. Turner,et al.  Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. , 1979, The New England journal of medicine.

[33]  N. Porksen,et al.  Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. , 1995, The American journal of physiology.

[34]  R. Gomis,et al.  Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. , 2002, Diabetes.

[35]  G. Wrenshall,et al.  Extractable Insulin of Pancreas: Correlation with Pathological and Clinical Findings in Diabetic and Nondiabetic Cases , 1952, Diabetes.

[36]  B H Frank,et al.  Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. , 1988, The American journal of physiology.

[37]  M. Straume,et al.  Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. , 2001, Diabetes.

[38]  J. Halter,et al.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.

[39]  Johannes D. Veldhuis,et al.  Induction of β-cell rest by a Kir6.2/SUR1-selective KATP-Channel opener preserves β-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose , 2004 .